Novavax Aktie
7,47
EUR
-0,23
EUR
-3,01
%
7,86
USD
-0,19
USD
-2,30
%
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 6 | 3 | 0 | 139,58 GBP | +20,43% |
| Bayer | 1 | 8 | 0 | 24,12 EUR | +10,87% |
| BioNTech (ADRs) | 4 | 2 | 0 | 136,17 USD | +16,04% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 2 | 6 | 2 | 43,92 EUR | +0,14% |
| Fresenius SE & Co. KGaA (St.) | 8 | 1 | 0 | 42,61 EUR | +16,96% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +105,02% |
| Novartis AG | 3 | 5 | 1 | 99,12 CHF | +2,55% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 30,40 USD | +17,65% |
| Roche AG (Genussschein) | 2 | 4 | 3 | 282,71 CHF | -4,26% |
| Sanofi S.A. | 6 | 2 | 0 | 114,14 EUR | +11,05% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |